Deep tech and life sciences with elite university spinouts
Switzerland has one of the most research-intensive startup ecosystems in Europe, anchored by ETH Zurich and EPFL. The country excels in deep tech, medtech, biotech, and fintech, with Zurich and Basel as the primary hubs. High capital availability, political stability, and proximity to major pharma and financial institutions make it a strong base for science-driven startups.
Two of the world's top technical universities generate a consistent pipeline of deep tech spinouts, many of which attract institutional VC from day one.
Proximity to pharma giants Roche and Novartis, and a dense network of CROs and medical device companies, creates a supportive environment for life science startups.
The Swiss innovation agency co-funds R&D projects between startups and research institutions, covering up to 50% of project costs without dilution.
Zurich's financial center and Switzerland's reputation for stability attract family offices, international VCs, and corporate venture arms with significant dry powder.
Use Pitchkit to create a professional pitch deck and find the right investors in Switzerland.